Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00168129

Enrollment

Registered

2005-09-15

Start date

2001-06-30

Completion date

2005-07-31

Last updated

2011-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Neoplasms

Keywords

tomotherapy, bone metastases, radiotherapy, intensity modulated

Brief summary

To assess the safety and efficacy of a single fraction of radiotherapy using helical tomotherapy to treat bone metastases.

Interventions

PROCEDUREHelical tomotherapy

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* painful metastatic bone disease from any malignancy

Exclusion criteria

* previous RT to same area * contraindications to RT

Design outcomes

Primary

Measure	Time frame
To deliver a single fraction of radiotherapy safely to patients with bone metastases using helical tomotherapy	—

Secondary

Measure	Time frame
To assess and quantify the acute toxicity of patients with bone metastases treated with helical tomotherapy.	—
To measure invivo dosimetry and compare delivered doses to computer-reconstructed dose distribution.	—
To determine the maximum tolerated does of palliative radiation give with helical tomotherapy in a single fraction.	—
To assess the efficacy (pain control) of radiotherapy given with helical tomotherapy.	—

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026